Flash Therapeutics
FranceEntry
2021
Hold
5yr
Status
Active
Who owns Flash Therapeutics?
Flash Therapeutics is a French Biotech company, currently owned by TechLife Capital since 2021 and Galia Gestion.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Most recent investor
TechLife CapitalTechLife Capital II · 2024 · Growth
2 ownership periods · full history below
Key facts
HQFrance
SectorBiotech
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2016 · present
Galia GestionActive
2016 · present(10yr) · Galia Investissements III · 2013
TechLife CapitalActive
2021 · present(5yr) · TechLife Capital II · 2024 · Growth
More from TechLife Capital II
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Flash Therapeutics?
Flash Therapeutics is currently owned by TechLife Capital and Galia Gestion, through TechLife Capital II, since 2021.
When did TechLife Capital and 1 other acquire Flash Therapeutics?
TechLife Capital and 1 other acquired Flash Therapeutics in 2021.
Who has owned Flash Therapeutics over time?
Flash Therapeutics has been through 2 private-equity ownership periods: Galia Gestion · via Galia Investissements III · since 2016; TechLife Capital · via TechLife Capital II · since 2021.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue